Sample size calculation

BT Babafemi O. Taiwo
LK Lisa M. Kuhns
OO Olayinka Omigbodun
OA Olutosin Awolude
KK Kehinde M. Kuti
AA Adedotun Adetunji
BB Baiba Berzins
PJ Patrick Janulis
SA Sulaimon Akanmu
OA Oche Agbaji
AD Agatha N. David
AA Akinsegun Akinbami
AA Abiodun Folashade Adekambi
AJ Amy K. Johnson
OO Ogochukwu Okonkwor
BO Bibilola D. Oladeji
MC Marbella Cervantes
OA Olubusuyi M. Adewumi
BK Bill Kapogiannis
RG Robert Garofalo
JF Joel Msafiri Francis
JF Joel Msafiri Francis
JF Joel Msafiri Francis
request Request a Protocol
ask Ask a question
Favorite

With a small to moderate within cluster correlation (ICC = 0.10) and moderate individual autocorrelation (0.50), this analysis will have adequate power (power = 0.945) to detect an OR of 1.5 in the proportion of participants achieving viral suppression with at least 90 participants per site. Our effect size estimate is conservative given that the iCARE UG3 pilot trial findings (OR = 14.0) was not randomized and not controlled. Findings from our prior randomized trial of text messaging on medication adherence (a related outcome) among YLH in the United States suggested an effect size of OR = 2.12 (95% CI 1.01–4.45).

Primary study data will be analyzed as soon as possible after the end of data collection, with study findings disseminated in peer-review public health journals.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A